Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia Meeting Abstract
| Authors: | Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; Garcia-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Palomba, M. L.; Matous, J.; Shustik, C.; Kastritis, E.; Treon, S. P.; Li, J.; Salman, Z.; Graef, T.; Buske, C. |
| Abstract Title: | Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 423s |
| Language: | English |
| ACCESSION: | WOS:000442916003050 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.8003 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8003 -- Source: Wos |
